Core View - Core Scientific, Inc. (NASDAQ:CORZ) has been upgraded from "Neutral" to "Buy" by H.C. Wainwright, with a price target set at $25.00, following recommendations from proxy advisory firms ISS and Glass Lewis against the proposed acquisition by CoreWeave (CRWV) [1][4]. Company Competencies - Core Scientific is recognized for its ability to rapidly develop compute-focused infrastructure at low costs, expertise in artificial intelligence compute builds, and a strong record in customer acquisition and support [2][3]. Market Position - The firm maintains a positive outlook on Core Scientific based on its proven track record and leadership in AI compute infrastructure, which has led to the rating upgrade [3][4]. Acquisition Context - The upcoming acquisition of Core Scientific by CoreWeave is facing opposition from leading proxy advisory firms, which may impact investor sentiment and the company's strategic direction [4]. Transition to AI - Core Scientific has successfully transitioned into an AI-focused business by leveraging advanced infrastructure and high-performance computing (HPC) expertise [4].
H.C. Wainwright Upgrades Core Scientific (CORZ) to Buy, Raises PT to $25